Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients
Institute of Hematology & Blood Diseases Hospital, China
50 participants
Jan 23, 2019
OBSERVATIONAL
Conditions
Summary
Evaluation of immune status before and after splenectomy in immune thrombocytopenia patients.
Eligibility
Inclusion Criteria4
- Aged 18 to 60 years old, male or female;
- Conform to the diagnostic criteria of immune Thrombocytopenia (ITP)
- Needed splenectomy;
- People who are willing to sign the informed consent voluntarily and follow the research program.
Exclusion Criteria3
- Secondary thrombocytopenic purpura;
- Patients with poor compliance;
- Researchers believe that patients should not participate in the test of any other condition.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
These patients should fail to have sustained response to multiple first- and second-line treatments of ITP and agree to have splenectomy.Before splenectomy, these patients will be reassessed and still diagnosed with ITP.Their platelet level will be raised to a safe state before surgery, and the laparoscopic splenectomy will be performed in Tianjin People's Hospital.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03998059